Literature DB >> 39562

Neocarzinostatin: spectral characterization and separation of a non-protein chromophore.

M A Napier, B Holmquist, D J Strydom, I H Goldberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39562     DOI: 10.1016/0006-291x(79)90677-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  18 in total

1.  Cold instability of aponeocarzinostatin and its stabilization by labile chromophore.

Authors:  Kandaswamy Jayachithra; Thallampuranam Krishnaswamy Suresh Kumar; Ta-Jung Lu; Chin Yu; Der-Hang Chin
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

2.  Selective abstraction of 2H from C-5' of thymidylate in an oligodeoxynucleotide by the radical center at C-6 of the diradical species of neocarzinostatin: chemical evidence for the structure of the activated drug-DNA complex.

Authors:  S M Meschwitz; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Studies on DNA-cleaving agents: computer modeling analysis of the mechanism of activation and cleavage of dynemicin-oligonucleotide complexes.

Authors:  P A Wender; R C Kelly; S Beckham; B L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  Molecular models of neocarzinostatin damage of DNA: analysis of sequence dependence in 5'GAGCG:5'CGCTC.

Authors:  A Galat; I H Goldberg
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

5.  DNA breakage activity of the methanol extract of auromomycin.

Authors:  D M Kalvin; C H Huang; M A Lischwe; E H Peters; A W Prestayko; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure.

Authors:  S E Schaus; D Cavalieri; A G Myers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells.

Authors:  N F Schor
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  The role of monoclonal antibody A7 as a drug modifier in cancer therapy.

Authors:  K Kitamura; T Miyagaki; N Yamaoka; H Tsurumi; A Noguchi; T Yamaguchi; T Takahashi
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

9.  Roles of chromophore and apo-protein in neocarzinostatin action.

Authors:  L S Kappen; M A Napier; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro.

Authors:  G Lüders; W Köhnlein; C Sorg; J Brüggen
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.